Soundbites: Cost-Effectiveness Analysis
Scan brief descriptions of cost-effectiveness analyses conducted by our center community and our decision science colleagues across the globe.
Scaling Cancer Prevention
This analysis used decision analytic modeling to estimate the health impact, costs, and cost-effectiveness of scaling-up HPV vaccination and cervical cancer screening in 50 low- and lower-middle-income countries.
Interventions that impose costs per DALY averted less than 3x and 1x GDP per capita are considered cost-effective and very cost-effective, respectively. This article explores the conceptual foundation and derivation of this threshold.